Several devices for treating essential tremor have been cleared by FDA. These include Fasikl’s Felix NeuroAI, a comparable ...

Neurent Medical has closed an oversubscribed Series C financing round, raising $74m to expand commercial activities for the ...

Abbott’s Volt pulsed-field ablation (PFA) system will be trialled across 15 NHS sites for the treatment of atrial ...

Natus Sensory has acquired TheraB Medical, a US-based company specialising in neonatal wearable phototherapy devices.

Merck and Calla Lily Clinical Care have announced a strategic partnership to advance Callavid, an intravaginal drug delivery platform.

Edwards’ financials reveal that its transcatheter mitral and tricuspid therapies (TMTT) portfolio grew by 56.4% in 2025.

In its Q1 fiscal 2026 financials, BD trimmed its EPS outlook by more than $2 at the high end due to the spin-off of its ...

The UK government has set out to improve access to healthcare technology within the National Health Service (NHS) through the ...

Asahi Kasei’s ZOLL has received approval for its Zenix monitor/defibrillator under the European Union Medical Device Regulation 2017/745.

A jury ruled that Medtronic violated multiple antitrust laws over its use of restrictive contracts with healthcare providers ...

Sonorous Neurovascular has received breakthrough device designation from the US FDA for its braided, self-expanding cerebral ...

Abbott has reported positive early data from the VERITAS study, evaluating its investigational Amulet 360 LAA occluder, ...